Literature DB >> 9876519

Controlled drug delivery by biodegradable poly(ester) devices: different preparative approaches.

R Jain1, N H Shah, A W Malick, C T Rhodes.   

Abstract

There has been extensive research on drug delivery by biodegradable polymeric devices since bioresorbable surgical sutures entered the market two decades ago. Among the different classes of biodegradable polymers, the thermoplastic aliphatic poly(esters) such as poly(lactide) (PLA), poly(glycolide) (PGA), and especially the copolymer of lactide and glycolide referred to as poly(lactide-co-glycolide) (PLGA) have generated tremendous interest because of their excellent biocompatibility, biodegradability, and mechanical strength. They are easy to formulate into various devices for carrying a variety of drug classes such as vaccines, peptides, proteins, and micromolecules. Most importantly, they have been approved by the United States Food and Drug Administration (FDA) for drug delivery. This review presents different preparation techniques of various drug-loaded PLGA devices, with special emphasis on preparing microparticles. Certain issues about other related biodegradable polyesters are discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9876519     DOI: 10.3109/03639049809082719

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  30 in total

1.  Effect of isopropyl myristic acid ester on the physical characteristics and in vitro release of etoposide from PLGA microspheres.

Authors:  M J Schaefer; J Singh
Journal:  AAPS PharmSciTech       Date:  2000-11-13       Impact factor: 3.246

2.  Biocompatibility of poly (3-hydroxybutyrate-co-3-hydroxyhexanoate) modified by silk fibroin.

Authors:  Na Mei; Ping Zhou; Luan-Feng Pan; Guang Chen; Chun-Gen Wu; Xin Chen; Zheng-Zhong Shao; Guo-Qiang Chen
Journal:  J Mater Sci Mater Med       Date:  2006-08       Impact factor: 3.896

Review 3.  IL-1Ra and its delivery strategies: inserting the association in perspective.

Authors:  Muhammad Sajid Hamid Akash; Kanwal Rehman; Shuqing Chen
Journal:  Pharm Res       Date:  2013-06-22       Impact factor: 4.200

4.  Tuning core vs. shell dimensions to adjust the performance of nanoscopic containers for the loading and release of doxorubicin.

Authors:  Lily Yun Lin; Nam S Lee; Jiahua Zhu; Andreas M Nyström; Darrin J Pochan; Richard B Dorshow; Karen L Wooley
Journal:  J Control Release       Date:  2011-01-15       Impact factor: 9.776

5.  Electrospray encapsulation of toll-like receptor agonist resiquimod in polymer microparticles for the treatment of visceral leishmaniasis.

Authors:  Anthony D Duong; Sadhana Sharma; Kevin J Peine; Gaurav Gupta; Abhay R Satoskar; Eric M Bachelder; Barbra E Wyslouzil; Kristy M Ainslie
Journal:  Mol Pharm       Date:  2013-02-12       Impact factor: 4.939

6.  New platform for controlled and sustained delivery of the EGF receptor tyrosine kinase inhibitor AG1478 using poly(lactic-co-glycolic acid) microspheres.

Authors:  Rebecca Robinson; James P Bertram; Jill L Reiter; Erin B Lavik
Journal:  J Microencapsul       Date:  2010-05       Impact factor: 3.142

Review 7.  Nitric oxide and cancer: a review.

Authors:  Sheetal Korde Choudhari; Minal Chaudhary; Sachin Bagde; Amol R Gadbail; Vaishali Joshi
Journal:  World J Surg Oncol       Date:  2013-05-30       Impact factor: 2.754

8.  Poly(lactide-co-glycolide) microspheres for MRI-monitored transcatheter delivery of sorafenib to liver tumors.

Authors:  Jeane Chen; Alexander Y Sheu; Weiguo Li; Zhuoli Zhang; Dong-Hyun Kim; Robert J Lewandowski; Reed A Omary; Lonnie D Shea; Andrew C Larson
Journal:  J Control Release       Date:  2014-04-13       Impact factor: 9.776

Review 9.  Current advances in research and clinical applications of PLGA-based nanotechnology.

Authors:  Jian-Ming Lü; Xinwen Wang; Christian Marin-Muller; Hao Wang; Peter H Lin; Qizhi Yao; Changyi Chen
Journal:  Expert Rev Mol Diagn       Date:  2009-05       Impact factor: 5.225

Review 10.  Advanced materials and processing for drug delivery: the past and the future.

Authors:  Ying Zhang; Hon Fai Chan; Kam W Leong
Journal:  Adv Drug Deliv Rev       Date:  2012-10-23       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.